Kelly Steven — SEC Form 4 filings
SEC reporting owner CIK 1339478. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2026-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARTELO BIOSCIENCES, INC. (ARTL) | Director | 4 | — | — | 15 |
| Carisma Therapeutics Inc. (CARM) | President and CEO, Director | 3 | — | — | 3 |
Form 4 filings — Kelly Steven
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 136 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 292 (derivative) @ $0 | EDGAR |
| 2025-01-30 | 4 | Carisma Therapeutics Inc. (CARM) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 1,750 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Carisma Therapeutics Inc. (CARM) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Disposition to issuer (D): 1,484 (derivative) · Disposition to issuer (D): 9,634 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 1,083 (derivative) · +6 more | EDGAR |
| 2024-02-02 | 4 | Carisma Therapeutics Inc. (CARM) | Grant/award (A): 438,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339478 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →